These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 4652242

  • 1. Excessive mortality in schizophrenic patients on chronic phenothiazines treatment.
    Matsuki A, Oyama T, Izai S, Zsigmond EK.
    Agressologie; 1972; 13(6):407-18. PubMed ID: 4652242
    [No Abstract] [Full Text] [Related]

  • 2. An uncontrolled clinical study with piperacetazine in the maintenance treatment of chronic schizophrenic patients.
    Amin MM, Brahm E, Ban TA, Lehmann HE.
    Psychopharmacol Bull; 1977 Jul; 13(3):10-1. PubMed ID: 18753
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The effectiveness of combined phenothiazine and butyrophenone treatment in chronic schizophrenic patients.
    Lehmann HE, Ban TA, Lee H.
    Curr Ther Res Clin Exp; 1967 Jan; 9(1):36-7. PubMed ID: 4963021
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. ["Depressive shift" in the course of treatment of schizophrenic psychosis with phenothiazines].
    Bohacek N.
    Neuropsihijatrija; 1967 Jan; 15(1):97-103. PubMed ID: 5191808
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. EEG signs of toxicity in schizophrenics on phenothiazines.
    Emde RN, Metcalf DR.
    Behav Neuropsychiatry; 1969 Nov; 1(8):31-6. PubMed ID: 5374544
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Thioproperazine: how dangerous is it?].
    Vinar O.
    Cesk Psychiatr; 1967 Aug; 63(4):274-6. PubMed ID: 4383546
    [No Abstract] [Full Text] [Related]

  • 12. Diabetes in chronic schizophrenia.
    Marinow A.
    Dis Nerv Syst; 1971 Nov; 32(11):777-8. PubMed ID: 5131772
    [No Abstract] [Full Text] [Related]

  • 13. [Comparative study of 2 drugs and a placebo in chronic schizophrenia].
    Tetreault L.
    Actual Pharmacol (Paris); 1969 Nov; 22():1-18. PubMed ID: 4927120
    [No Abstract] [Full Text] [Related]

  • 14. High dosage piperacetazine (Quide) in ambulatory schizophrenic patients--therapeutic efficacy and toxicity.
    Donlon PT, Rada RT.
    Dis Nerv Syst; 1974 May; 35(5):231-6. PubMed ID: 17894106
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Agranulocytosis and phenothiazines.
    Mandel A, Gross M.
    Dis Nerv Syst; 1968 Jan; 29(1):32-6. PubMed ID: 5635744
    [No Abstract] [Full Text] [Related]

  • 17. Controlled study of BL-KR140 on chronic anergic schizophrenic patients stabilized with a neuroleptic compound.
    Dim BH, Kurland AA.
    Curr Ther Res Clin Exp; 1968 Jun; 10(6):288-91. PubMed ID: 4969835
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Proketazine in the treatment of schizophrenia].
    Jakubik A, Aleksandrowicz J.
    Neurol Neurochir Psychiatr Pol; 1965 Jun; 15(4):639-45. PubMed ID: 5843584
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.